期刊文献+

成人社区获得性尿路感染细菌病原学研究 被引量:1

BACTERIAL ETIOLOGY RESEARCH OF ADULTS COMMUNITY-ACQUIRED URINARY TRACT INFECTION
下载PDF
导出
摘要 [目的]探讨近年成人社区获得性尿路感染(CA-UTI)细菌病原学特点。[方法]采用法国Bio Merieux VITEK2型全自动微生物仪对CA-UTI患者432株细菌进行菌种鉴定(ID卡)及药物敏感试验(AST卡),用WHONET5软件统计出细菌构成比与耐药率。[结果]检测标本的细菌分离率为39.1%(402/1027),检出细菌中革兰阴性菌占77.8%(336/432),其中大肠埃希菌占51.4%(222/432)。革兰阴性菌对新型β-内酰胺类最敏感,其次为阿米卡星及第三代头孢菌素,对氨苄西林、头孢唑啉、磺胺等高度抗药。革兰阳性菌对左氧氟沙星、氨苄西林/舒巴坦及利福平等较敏感。[结论]成人CA-UTI病原菌构成在发生变迁,细菌的耐药性也在发生改变,做好各地各时期感染性疾病病原检测及耐药性监测,可提高病原学诊断水平和用药选择水平,提高医疗质量。 [ Objective ] To explore the bacterial etiology feature of community-acquired urinary tract infection (CA-UTI) in recent years. [ Methods] French Bio merieux VITEK 2-automatic microbial instrument was used to identify the category (ID card) and test the drug susceptibility (AST card) of 432 strains of bacteria. The bacteria composing ratio and drug resistance rate were also deternfined.[Results] The bacteria isolated rate was 39.1% (402/1027) . Gram-negative bacilli bacteria accounted for 77.8% (336/432) and escherichia coli accounted for 51.4% (222/432) . Gram-negative bacteria was most sensitive to new beta-lactam, amikaein and third-generation cephalosporins was the second. It had high resistance to ampieillin, cefazoin and sulphanilamide. Gram-positive bacteria was most sensitive to levofloxacin, ampicillin/sulbactam and rifampin. [ Conclusion] The composition of adult CA-UTI pathogens is changing and the resistance of bacteria is also changing. The pathogenic detection of infectious diseases and monitoring of resistance can improve the diagnosis of etiology, treatment options and medical quality.
出处 《现代预防医学》 CAS 北大核心 2007年第13期2447-2449,共3页 Modern Preventive Medicine
关键词 社区 成人 泌尿系统感染 细菌 耐药率 Community Adults Urinary tract infection Bacteria Resistance
  • 相关文献

参考文献7

  • 1王海燕.肾脏病学[M](第2版)[M].北京:人民卫生出版社,1997.1385.
  • 2糜祖煌,陆亚华.氨基糖苷类修饰酶及其基因检测[J].现代实用医学,2004,16(1):13-14. 被引量:143
  • 3Farrell D J,Morrissey I,de Rubeis D,et al.A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection[J].J Infect,2003,46 (2):94-100.
  • 4Ronald A R,Harding G K.Complicated urinary tract infections[J].Infect Dis Clin North Am,1997,11 (3):583-592.
  • 5Gordon K A,Jones R N.Sentry Participant Groups (Europe,Latin America,North America).Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America:comparison report to Europe and Latin America[J].Diagn Microbiol Infect Dis,2003,45(4):295-301.
  • 6马越,李景云,张新妹,张力,胡昌勤,金少鸿.2002年临床常见细菌耐药性监测[J].中华检验医学杂志,2004,27(1):38-45. 被引量:460
  • 7季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172

二级参考文献19

  • 1Bauernfeind A, Stemplinger I, Jungwirth R, et al. Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother, 1996,40:509-513.
  • 2Coque TM, Oliver A, Perez-Diaz JC, et al. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother, 2002,46:50
  • 3Chanawong A, M′Zali FH, Heritage J, et al. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002,46:630-637.
  • 4Yan JJ, Wu SM, Tsai SH, et al. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother, 2000,44:143
  • 5Bonfiglio G, Perilli M, Stefani S, et al. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey. Int J Antimicrob Agents, 2002,19:213-217.
  • 6Tzelepi E, Magana Ch, Platsouka E, et al. Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents, 2003,21:285-288.
  • 7Yagi T, Kurokawa H, Shibata N, et al. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett, 2000,184:53-56.
  • 8Xiong Z, Zhu D, Wang F, et al. Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis, 2002,44:195-200.
  • 9Wang H, Kelkar S, Wu W, et al. Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother, 2003,47:790-793.
  • 10Arduino SM, Roy PH, Jacoby GA, et al. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother, 2002,46:2303-2306.

共引文献792

同被引文献14

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部